Skip to main content

Table 1 Clinicopathologic features of patients with AC-predominant and SCC-predominant adenosquamous carcinoma

From: Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma

Variable

ASC Total (N,%)

AC-predominant (n = 39)

SCC-predominant (n = 29)

p-value

Age(y)

58.6 ± 11.5

59.9 ± 10.1

57.6 ± 12.6

0.096

Gender

   

0.746

 Male

46 (67.6%)

27

19

 

 Female

22 (32.4%)

12

10

 

Smoking history

   

0.276

 Yes

38 (55.9%)

24

14

 

 No

30 (44.1%)

15

15

 

CEA (ng/ml)

6.40 (3–20.36)

8.47 (3–28.73)

5.07 (2.43–14.4)

0.327

T-stage

   

0.986

 T1 ~ T2

54 (79.4%)

31

23

 

 T3

14 (20.6%)

8

6

 

N-stage

   

0.857

 N0

18 (26.5%)

10

8

 

 N1 ~ 2

50 (73.5%)

29

21

 

TNM-stage

   

0.919

 I ~ II

38 (55.9%)

22

16

 

 IIIA

30 (44.1%)

17

13

 

Surgical procedures

   

0.291

 Wedge

2 (2.9%)

2

0

 

 Lobectomy

56 (82.4%)

30

26

 

 Extended resection

10 (14.7%)

7

3

 
  1. AC adenocarcinoma, SCC squamous cell carcinoma, CEA carcinoembryonic antigen